Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             36 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A Comparison of Globally Applied Prognostic Risk Groups and the Prevalence of Metastatic Disease on Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer Luining, Wietske I.

8 3 p. 632-640
artikel
2 American Radium Society Appropriate Use Criteria for the Workup and Treatment of Local Intraprostatic Recurrence of Prostate Cancer Following Definitive Radiotherapy Valle, Luca F.

8 3 p. 796-804
artikel
3 A Nationwide Real-world Evaluation of Upfront Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Renal Cell Carcinoma in the Immunotherapy Era Yildirim, Hilin

8 3 p. 623-631
artikel
4 Benefit and Harms of Radical Nephroureterectomy as Part of a Multimodal Treatment Strategy for Upper Tract Urothelial Carcinoma Patients Presenting with Clinical Evidence of Regional Lymph Node Metastasis: A Systematic Review and Meta-analysis by the European Association of Urology Guidelines Rai, Bhavan Prasad

8 3 p. 841-852
artikel
5 Challenges in Defining Clinical Complete Response to Systemic Therapy in Muscle-invasive Bladder Cancer: Insights from the EORTC STARBURST Project Masson-Lecomte, Alexandra

8 3 p. 603-607
artikel
6 Circulating Tumor DNA: A New Research Frontier in Urological Oncology from Localized to Metastatic Disease Garofoli, Marianna

8 3 p. 805-817
artikel
7 Colibactin Exerts Androgen-dependent and -independent Effects on Prostate Cancer Agrawal, Raag

8 3 p. 716-730
artikel
8 Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate Cancer Ravi, Praful

8 3 p. 709-715
artikel
9 Contents
8 3 p. iii-viii
artikel
10 Correlation of Body Mass Index with Overall Survival Among Patients with Metastatic Hormone-sensitive Prostate Cancer: Analysis of Patient-level Data from SWOG-1216 Swami, Umang

8 3 p. 612-615
artikel
11 Cost-effectiveness Analysis in the New Era of Treatment Strategies in Metastatic Urothelial Carcinoma Based on Checkmate-901 and EV302/Keynote-A39 Rieger, Constantin

8 3 p. 681-688
artikel
12 Cost-utility Analysis of Navigate, a Treatment Decision Aid for Men with Prostate Cancer and Their Partners, in Comparison to Usual Care Lindsay, Daniel

8 3 p. 674-680
artikel
13 Digital Pathology–based Artificial Intelligence Biomarker Validation in Metastatic Prostate Cancer Markowski, Mark C.

8 3 p. 755-762
artikel
14 Early Oncological Outcomes in Patients who Underwent Staging Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging Before Radical Prostatectomy and Extended Pelvic Lymph Node Dissection Ettema, Rosemarijn H.

8 3 p. 739-746
artikel
15 Editorial Board
8 3 p. i-ii
artikel
16 Hall of Fame
8 3 p. ix
artikel
17 Hospital Volume as a Determinant of Outcomes After Partial Nephrectomy: A Systematic Review by the European Association of Urology Renal Cell Carcinoma Guidelines Panel Marconi, Lorenzo

8 3 p. 616-622
artikel
18 Is Frequent Imaging Necessary? Impact of Computed Tomography During Follow-up After Surgical Treatment for Nonmetastatic Renal Cell Carcinoma: A Systematic Review van den Brink, Luna

8 3 p. 829-840
artikel
19 Patients’ Preferences for Cytoreductive Treatments in Newly Diagnosed Metastatic Prostate Cancer: The IP5-MATTER Study Connor, Martin J.

8 3 p. 663-673
artikel
20 Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort D Yu, Evan Y.

8 3 p. 641-651
artikel
21 Prediction of Clinically Significant Prostate Cancer by a Specific Collagen-related Transcriptome, Proteome, and Urinome Signature Heidegger, Isabel

8 3 p. 652-662
artikel
22 Re: Bertrand F. Tombal, Francisco Gomez-Veiga, Alvaro Gomez-Ferrer, et al. A Phase 2 Randomized Open-label Study of Oral Darolutamide Monotherapy Versus Androgen Deprivation Therapy in Men with Hormone-sensitive Prostate Cancer (EORTC-GUCG 1532). Eur Urol Oncol 2024;7:1051–60 Montorsi, Francesco

8 3 p. 856
artikel
23 Recent and Future Developments in the Use of Poly (ADP-ribose) Polymerase Inhibitors for Prostate Cancer Zacchi, Francesca

8 3 p. 818-828
artikel
24 Reducing Overtreatment of Prostate Cancer Patients: Revisiting the European Association of Urology Pretreatment Risk Group Classification Using Long-term Follow-up Data from the European Randomized Study of Screening for Prostate Cancer Rotterdam de Vos, Ivo I.

8 3 p. 747-754
artikel
25 Reply to Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, and Alberto Briganti’s Letter to the Editor re: Bertrand F. Tombal, Francisco Gomez-Veiga, Alvaro Gomez-Ferrer, et al. A Phase 2 Randomized Open-label Study of Oral Darolutamide Monotherapy Versus Androgen Deprivation Therapy in Men with Hormone-sensitive Prostate Cancer (EORTC-GUCG 1532). Eur Urol Oncol 2024;7:1051–60 Tombal, Bertrand

8 3 p. 853
artikel
26 Reply to Ignacio Puche-Sanz, Ugo Giovanni Falagario, Giorgio Gandaglia, et al’s Letter to the Editor re: Evelien J.E. van Altena, Bernard H.E. Jansen, Marieke L. Korbee, et al. Prostate-specific Membrane Antigen Positron Emission Tomography Before Reaching the Phoenix Criteria for Biochemical Recurrence of Prostate Cancer After Radiotherapy: Earlier Detection of Recurrences. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2024.09.015 van Altena, Evelien J.E.

8 3 p. 854-855
artikel
27 Results of Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma in a Large Multicenter Series Abancourt, Ludwige

8 3 p. 774-781
artikel
28 Sex Disparity in Non–muscle-invasive Bladder Cancer: Pitfalls of Large Population-based Data Sets and Lessons from an Integrated Analysis Lobo, Niyati

8 3 p. 608-611
artikel
29 Stereotactic Radiation for Primary Renal Cell Carcinoma: Is It Ready for Prime Time? Hannan, Raquibul

8 3 p. 597-600
artikel
30 Suffering in Silence: Loneliness Among Men with Prostate Cancer and the Potential for Exercise as Connection Winters-Stone, Kerri

8 3 p. 792-795
artikel
31 The Added Value of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography to Magnetic Resonance Imaging for Local Staging of Prostate Cancer in Patients Undergoing Radical Prostatectomy Soeterik, Timo F.W.

8 3 p. 731-738
artikel
32 Total and Regional Changes in Body Composition in Metastatic Hormone-sensitive Prostate Cancer Patients Randomized to Receive Androgen Deprivation + Enzalutamide ± Zoledronic Acid. The BONENZA Study Buffoni, Martina

8 3 p. 782-791
artikel
33 Treatment of Metastatic Renal Cell Carcinoma: Lack of Consensus Urges the Need for a Well-organized Multidisciplinary Team Muselaers, Stijn

8 3 p. 601-602
artikel
34 Treatment Response Assessment According to Updated PROMISE Criteria in Patients with Metastatic Prostate Cancer Using an Automated Imaging Platform for Identification, Measurement, and Temporal Tracking of Disease Benitez, Cecil M.

8 3 p. 700-708
artikel
35 Two-fraction Versus Five-fraction Stereotactic Body Radiotherapy for Intermediate-risk Prostate Cancer: The TOFFEE Meta-analysis of Individual Patient Data from Four Prospective Trials Udovicich, Cristian

8 3 p. 763-773
artikel
36 Value of Whole-body Magnetic Resonance Imaging Using the MET-RADS-P Criteria for Assessing the Response to Intensified Androgen Deprivation Therapy in Metastatic Hormone-naïve and Castration-resistant Prostate Cancer Van Damme, Julien

8 3 p. 689-699
artikel
                             36 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland